SCHEMBL24952134

SCHEMBL24952134

CC(C)(C)OC(=O)CCOCCOCCOCC[PH](c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR2 O60603 2/20 0.39
TLR1 Q15399 2/20 0.39
CYP2C19 P33261 1/20 0.36
HIF1A Q16665 1/20 0.36
MTNR1A P48039 1/20 0.34
MTNR1B P49286 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
PTPN1 P18031 1/20 0.33
ACE P12821 1/20 0.33
ALDH1A1 P00352 2/20 0.33
KMT2A Q03164 2/20 0.33
STING1 Q86WV6 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
GAA P10253 1/20 0.33
RAB9A P51151 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA7 P43166 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24951291 1.00 TLR2 (0.39) TLR2TLR1CYP2C19HIF1AMTNR1A
SCHEMBL28594635 0.86 MTNR1A (0.37) CYP2C19HIF1AMTNR1AMTNR1BL3MBTL1
SCHEMBL20151858 0.84 HDAC8 (0.40) CYP2C19HIF1AMTNR1AMTNR1BL3MBTL1
Bromide SCHEMBL28950639 0.82 HDAC8 (0.39) CYP2C19HIF1AMTNR1AMTNR1BL3MBTL1
SCHEMBL24952122 0.80 LMNA (0.41) CYP2C19L3MBTL1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL24952207 0.80 LMNA (0.41) CYP2C19L3MBTL1ALDH1A1KMT2ASMN1; SMN2
SCHEMBL26023523 0.79 L3MBTL1 (0.51) TLR2TLR1L3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL24386940 0.79 L3MBTL1 (0.51) TLR2TLR1L3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL24207942 0.79 L3MBTL1 (0.51) TLR2TLR1L3MBTL1ALDH1A1SMN1; SMN2
SCHEMBL3590948 0.78 TDP1 (0.49) L3MBTL1ALDH1A1KMT2AMEN1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11560395-B2 Azithromycin derivatives containing a phosphonium ion as anticancer agents RISING TIDE FOUND (CH) 2023-01-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11560395-B2 Azithromycin derivatives containing a phosphonium ion as anticancer agents NUP205, PHPT1, PHOSPHO1 TLR2 4758/4885TLR1 4797/4885CYP2C19 4069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.